Literature DB >> 32735888

Circular RNA hsa_circ_0001588 promotes the malignant progression of lung adenocarcinoma by modulating miR-524-3p/NACC1 signaling.

Zhaoyi Sun1.   

Abstract

AIMS: Previous studies have demonstrated that circular RNAs play significant roles in several tumors, including lung adenocarcinoma; however, specific biological functions and molecular mechanisms underlying this process remain unclear.
MATERIALS AND METHODS: Here, we conducted real-time quantitative PCR (qRT-PCR) to measure hsa_circ_0001588 expression levels in 60 paired lung adenocarcinoma tissues and cell lines. Furthermore, the association between hsa_circ_0001588 and clinical features of lung adenocarcinoma was analyzed. Functional experiments were conducted to assess the influence of hsa_circ_0001588 on proliferation, migration, and invasion in lung adenocarcinoma cells. We detected possible downstream targets of hsa_circ_0001588 using bioinformatics analysis. Luciferase reporter assays, qRT-PCR, and western blotting assays were performed to verify the molecular mechanism underlying hsa_circ_0001588 functions. KEY
FINDINGS: We found that hsa_circ_0001588 was prominently upregulated in lung adenocarcinoma tissues and cell lines; elevated expression of hsa_circ_0001588 was positively correlated with poor clinicopathological features of lung adenocarcinoma. Functional experiments revealed that hsa_circ_0001588 acts as an oncogene to promote the proliferation, migration, and invasion of lung adenocarcinoma in vitro. Mechanistically, hsa_circ_0001588 promoted the proliferation, migration, and metastasis of lung adenocarcinoma by binding to miR-524-3p to promote nucleus accumbens-associated protein 1(NACC1) expression. SIGNIFICANCE: Together, our results revealed that hsa_circ_0001588 upregulated the expression of NACC1 by combining with miR-524-3p to promote the proliferation, migration, and invasion of lung adenocarcinoma cells, suggesting that hsa_circ_0001588 may be an underlying therapeutic target for lung adenocarcinoma.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Lung adenocarcinoma; Malignant progression; NACC1; hsa_circ_0001588; miR-524-3p

Mesh:

Substances:

Year:  2020        PMID: 32735888     DOI: 10.1016/j.lfs.2020.118157

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

1.  Circular RNA hsa-circ-000881 suppresses the progression of lung adenocarcinoma in vitro via a miR-665/PRICKLE2 axis.

Authors:  Chu Huang; Weiming Yue; Lin Li; Shuhai Li; Cun Gao; Libo Si; Lei Qi; Chuanle Cheng; Ming Lu; Guanqing Chen; Jingjing Cui; Renchang Zhao; Yongmeng Li; Hui Tian
Journal:  Ann Transl Med       Date:  2021-03

2.  Activating transcription factor 3-activated long noncoding RNA forkhead box P4-antisense RNA 1 aggravates colorectal cancer progression by regulating microRNA-423-5p/nucleus accumbens associated 1 axis.

Authors:  Zhouyang Cheng; Song Jiang; Ran Tao; Haipeng Ge; Jun Qin
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

3.  circHIPK3 regulates cell proliferation and migration by sponging microRNA-124 and regulating serine/threonine kinase 3 expression in esophageal squamous cell carcinoma.

Authors:  Da Yao; Shengcheng Lin; Size Chen; Zhe Wang
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

4.  Tumorous expression of NAC1 restrains antitumor immunity through the LDHA-mediated immune evasion.

Authors:  Yijie Ren; Anil Kumar; Jugal K Das; Hao-Yun Peng; Liqing Wang; Darby Balllard; Xiaofang Xiong; Xingcong Ren; Yi Zhang; Jin-Ming Yang; Jianxun Song
Journal:  J Immunother Cancer       Date:  2022-09       Impact factor: 12.469

Review 5.  Circular RNAs in Lung Cancer: Recent Advances and Future Perspectives.

Authors:  Huan-Huan Chen; Tie-Ning Zhang; Qi-Jun Wu; Xin-Mei Huang; Yu-Hong Zhao
Journal:  Front Oncol       Date:  2021-07-06       Impact factor: 6.244

6.  circ_0001588 Induces the Malignant Progression of Hepatocellular Carcinoma by Modulating miR-874/CDK4 Signaling.

Authors:  Xiaoyun Bin; Yichen Chen; Jiasheng Ma; Renchao Tang; Zhenrong Zhao; Kangxuan Wang; Jianchu Wang
Journal:  J Immunol Res       Date:  2021-10-20       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.